BriaCell Therapeutics
(NASDAQ:BCTX)
$1.43
0.04[2.88%]
At close: May 20
$1.43
0[0.00%]
PreMarket: 3:24AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

BriaCell Therapeutics Stock (NASDAQ:BCTX), Quotes and News Summary

BriaCell Therapeutics Stock (NASDAQ: BCTX) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.711.000 / 77.756K
Day Range- - -
52 Wk Range1.300 - 7.590
Market Cap$22.854M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
24
Short Interest
4.77%
Days to Cover17.72

Recent News

BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
BriaCell Therapeutics Corp (NASDAQ: BCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients that have developed resistance to (and failed to respond to) 
Vandana Singh
Sponsored
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX<
Sponsored
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption.
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BCTX

FAQ

Q

How do I buy BriaCell Therapeutics (BCTX) stock?

A

You can purchase shares of BriaCell Therapeutics (NASDAQ: BCTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BriaCell Therapeutics's (BCTX) competitors?

A

There are no as such competitors for BriaCell Therapeutics.

Q

What is the target price for BriaCell Therapeutics (BCTX) stock?

A

The latest price target for BriaCell Therapeutics (NASDAQ: BCTX) was reported by HC Wainwright & Co. on Thursday, December 28, 2023. The analyst firm set a price target for 18.00 expecting BCTX to rise to within 12 months (a possible 1158.74% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BriaCell Therapeutics (BCTX)?

A

The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $1.43 last updated Today at May 20, 2024 at 3:24 AM EDT.

Q

Does BriaCell Therapeutics (BCTX) pay a dividend?

A

There are no upcoming dividends for BriaCell Therapeutics.

Q

When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?

A

BriaCell Therapeutics’s Q3 earnings are confirmed for Wednesday, June 12, 2024.

Q

Is BriaCell Therapeutics (BCTX) going to split?

A

There is no upcoming split for BriaCell Therapeutics.

Q

What sector and industry does BriaCell Therapeutics (BCTX) operate in?

A

BriaCell Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.